p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Brehima DiakiteYaya KassogueGuimogo DoloJun WangErin NeuschlerOumar KassogueMamadou L KeitaCheick B TraoreBakarou KamateEtienne DembeleSellama NadifiRobert L MurphySeydou DoumbiaLifang HouMamoudou MaigaPublished in: BMC medical genetics (2020)
This meta-analysis found a significant association between TP53 p.Arg72Pro polymorphism and the risk of breast cancer. Individuals carrying at least one Pro allele were more likely to have breast cancer than individuals harboring the Arg allele.